1. Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial. Issue 1 (28th December 2021) Authors: Stewart, Adam G; Henderson, Andrew; Bauer, Michelle J; Paterson, David L; Harris, Patrick N A Journal: JAC-antimicrobial resistance Issue: Volume 4:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa. (17th December 2020) Authors: Isler, Burcu; Harris, Patrick; Stewart, Adam G; Paterson, David L Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 3(2021) Page Start: 550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa–—authors' response. (8th October 2021) Authors: Isler, Burcu; Harris, Patrick; Stewart, Adam G; Paterson, David L Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 12(2021) Page Start: 3327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Completing the Picture—Capturing the Resistome in Antibiotic Clinical Trials. (23rd December 2020) Authors: Stewart, Adam G; Satlin, Michael J; Schlebusch, Sanmarié; Isler, Burcu; Forde, Brian M; Paterson, David L; Harris, Patrick N A Journal: Clinical infectious diseases Issue: Volume 72:Number 12(2021) Page Start: e1122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Erratum to: Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections. (28th October 2020) Authors: Stewart, Adam G; Harris, Patrick N A; Henderson, Andrew; Schembri, Mark A; Paterson, David L Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 1(2021) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2). (2nd August 2021) Authors: Stewart, Adam G; Paterson, David L; Young, Barnaby; Lye, David C; Davis, Joshua S; Schneider, Kellie; Yilmaz, Mesut; Dinleyici, Rumeysa; Runnegar, Naomi; Henderson, Andrew; Archuleta, Sophia; Kalimuddin, Shirin; Forde, Brian M; Chatfield, Mark D; Bauer, Michelle J; Lipman, Jeffrey; Harris-Brown, ... Journal: Open forum infectious diseases Issue: Volume 8:Number 8(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Modern Clinician-initiated Clinical Trials to Determine Optimal Therapy for Multidrug-resistant Gram-negative Infections. (18th November 2019) Authors: Stewart, Adam G; Harris, Patrick N A; Chatfield, Mark; Evans, Scott R; van Duin, David; Paterson, David L Journal: Clinical infectious diseases Issue: Volume 71:Number 2(2020) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections. (22nd May 2020) Authors: Stewart, Adam G; Harris, Patrick N A; Henderson, Andrew; Schembri, Mark A; Paterson, David L Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 9(2020) Page Start: 2384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗